BioLife Solutions BLFS CryoStor — Concentration risk (in percent)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's cryostor — concentration risk (in percent).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's cryostor — concentration risk (in percent)?
- BioLife Solutions (BLFS) reported cryostor — concentration risk (in percent) of 82% in Q1 2026.
- How has BioLife Solutions's cryostor — concentration risk (in percent) changed year-over-year?
- BioLife Solutions's cryostor — concentration risk (in percent) decreased by 2.4% year-over-year, from 84% to 82%.
- What is the long-term trend for BioLife Solutions's cryostor — concentration risk (in percent)?
- Over 2 years (2023 to 2025), BioLife Solutions's cryostor — concentration risk (in percent) has grown at a 17.9% compound annual growth rate (CAGR), from 174% to 242%.
- What does cryostor — concentration risk (in percent) mean?
- This metric measures the percentage of total segment revenue derived from a limited number of key customers or specific high-value contracts. A higher concentration indicates increased vulnerability to the loss of a major client or shifts in their procurement strategy. Monitoring this ratio helps assess the stability and diversification of the revenue stream within the biopreservation product line.